Provenance
Developed by SPS, the British Association for Sexual Health and HIV (BASHH), the British Association of HIV (BHIVA) and the support of specialist stakeholders working within clinical practice for sexual health services.
Template versions available
Version 3.0 of this PGD template, valid from April 2026, has been published to allow organisations to undertake local governance processes in a timely manner.
Version 2.1 of this PGD template remains currently valid and will be removed from this page on its expiry (31st March 2026).
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).
More sexual health PGD templates
- Podophyllotoxin (topical) for external anogenital warts
- Imiquimod 5% w/w cream for anogenital warts
- Emtricitabine and tenofovir alafenamide (TAF) tablets as PrEP
- Emtricitabine and tenofovir disoproxil (TD) tablets as PrEP
- Ceftriaxone intramuscular injection for Neisseria gonorrhoeae
- Doxycycline for use within sexual health services
- Aciclovir (oral) for genital HSV infection
- Clotrimazole cream for candidiasis and candidal balanoposthitis
- Clotrimazole pessaries for candidiasis
- Fluconazole 150mg capsules for candidiasis
- Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
- Metronidazole (oral) for use within sexual health services
- Doxycycline post exposure prophylaxis (doxyPEP)
All PGD templates
National PGD, protocol and written instructions templates
National templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Version 3.0 PGD template added
- Version 2.1 published to reflect SPC changes
- Title, URL and summary amended.
- Version 1 removed as expiring end March '23
- Version 2.0 PGD template added
- Published